The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement.
about
Neuroendocrine immunoregulation in multiple sclerosisNeuroprotective effects of estrogens and androgens in CNS inflammation and neurodegenerationProgesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitisProgesterone alleviates neural behavioral deficits and demyelination with reduced degeneration of oligodendroglial cells in cuprizone-induced miceSex-related factors in multiple sclerosis susceptibility and progression.Progesterone synthesis in the nervous system: implications for myelination and myelin repair.Progesterone and autoimmune disease.Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy[Immunity impact of pregnancy on the experience of the Obstetrics and Gynecology Department of Moulay Ismail Military Hospital].The role of postpartum intravenous corticosteroids in the prevention of relapses in multiple sclerosisSex differences in a mouse model of multiple sclerosis: neuropathic pain behavior in females but not males and protection from neurological deficits during proestrus.Gender issues in multiple sclerosis: an update.Female reproductive issues in multiple sclerosis.The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis.Interdisciplinary exchange of ideas: progestagens for autoimmunity, biologics for pregnancy complications.Multiple sclerosis and pregnancy in the 'treatment era'.Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis.Organotypic cultures of cerebellar slices as a model to investigate demyelinating disorders.Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.Predictors and dynamics of postpartum relapses in women with multiple sclerosis.Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding.Hormones and MS: Risk factors, biomarkers, and therapeutic targets.Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort.Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches
P2860
Q26864449-F377E4B8-C423-4A63-B732-C13A193EC391Q27023974-F265E7EE-4391-41D0-B22A-F622D2960E36Q33716702-DF2CAD03-D8DD-4148-B799-7B5039FDEBA7Q34566512-8D4A7164-B9F8-4992-929D-5040983B21E0Q35619427-3F3EEDDF-7569-424D-98E5-9BF9C54D6DC7Q35743169-198612A4-F909-41AA-8248-6605193BF2D0Q36202227-7E0B9EFF-5B21-46D7-9848-302AF0EBFE4EQ36298897-0F437311-02E7-4DEC-9B34-FC6EFE1893B0Q37242396-C6BEA8F8-C13E-4F14-9995-D3C154B3B760Q37442072-02BA95BF-2A6E-429C-80CC-A64AFB752083Q37681814-4172CE42-6001-44DD-8D16-1E9CA88A3D73Q37813691-4F215CDF-0E32-4B05-88FE-074EE6933D7EQ38021743-A3487B7F-B4F9-4D66-9235-80262E7BB6A8Q38190349-1667B156-BDB8-42E8-A426-E30F021FEC8FQ38304259-2B349FFE-34C2-45D0-93B1-287F37BCE03EQ38431744-D5FD6714-A7CD-47BB-8136-0DC59B7AFC15Q38616570-29D1E987-0273-47C1-A67A-1007C2042C8AQ39437479-5B35C941-7E8D-40AB-810D-4CDE295F50C4Q44106109-A5FD3263-054A-4A3E-B612-BA441E15C6DAQ45832934-E98D6AD8-544B-4743-9BB5-E54C75711527Q46145241-B8AD1280-6F2A-44CA-86AF-E2EE465DED89Q47747865-0331F1EF-C471-41DA-A7D5-D78B2A75C7BBQ48333424-DCDDC6F0-23F5-4E80-8985-802320522727Q48679107-BB50A4A8-FA12-4A6A-89DD-289F835A2008Q58737028-68B17B97-E7BF-4913-993C-BBC9ABCDE726
P2860
The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The Prevention of Post-Partum ...... ives and state of advancement.
@en
The Prevention of Post-Partum ...... ives and state of advancement.
@nl
type
label
The Prevention of Post-Partum ...... ives and state of advancement.
@en
The Prevention of Post-Partum ...... ives and state of advancement.
@nl
prefLabel
The Prevention of Post-Partum ...... ives and state of advancement.
@en
The Prevention of Post-Partum ...... ives and state of advancement.
@nl
P2093
P1476
The Prevention of Post-Partum ...... ives and state of advancement.
@en
P2093
C Confavreux
E E Baulieu
M Schumacher
Prevention of Post-Partum Rela ...... ultiple Sclerosis Study Group
P304
P356
10.1016/J.JNS.2009.08.056
P577
2009-09-15T00:00:00Z